lobbying_activities: 1374354

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1374354	b85bdb78-7b7e-48b9-b9ba-c4ae78973eb8	Q1	CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.	8511	ONYX PHARMACEUTICALS	2013	first_quarter	MED	Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE	30000		0	0	2013-04-17T11:17:55.417000-04:00